NO965593L - Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria - Google Patents

Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria

Info

Publication number
NO965593L
NO965593L NO965593A NO965593A NO965593L NO 965593 L NO965593 L NO 965593L NO 965593 A NO965593 A NO 965593A NO 965593 A NO965593 A NO 965593A NO 965593 L NO965593 L NO 965593L
Authority
NO
Norway
Prior art keywords
aqueous
mycobacteria
cell
extracts
wall fractions
Prior art date
Application number
NO965593A
Other languages
Norwegian (no)
Other versions
NO965593D0 (en
Inventor
Hans-Georg Laves
Anne Thomsen
Original Assignee
Laves Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laves Arzneimittel Gmbh filed Critical Laves Arzneimittel Gmbh
Publication of NO965593D0 publication Critical patent/NO965593D0/en
Publication of NO965593L publication Critical patent/NO965593L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Vandige ekstrakter av som regel ikke-menneskepatogene mykobakterier som er kjennetegnet ved at ekstraktene i en cytokintest etter J. Immunol. 120: 2027-2032, ved en konsentrasjonsendring fra 1:4 til 1:16 gir en forhøyelse av innholdet av cytokinene IL-1 og IL-6 i forholdet 1:6, hhv. 1:1,25.Aqueous extracts of usually non-human pathogenic mycobacteria characterized by the extracts in a cytokine test after J. Immunol. 120: 2027-2032, at a concentration change from 1: 4 to 1:16, gives an increase in the content of cytokines IL-1 and IL-6 in the ratio 1: 6, respectively. 1: 1.25.

NO965593A 1994-06-30 1996-12-27 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria NO965593L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4422859A DE4422859C2 (en) 1994-06-30 1994-06-30 Aqueous cell extracts from mycobacteria
PCT/EP1995/002524 WO1996000579A1 (en) 1994-06-30 1995-06-29 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria

Publications (2)

Publication Number Publication Date
NO965593D0 NO965593D0 (en) 1996-12-27
NO965593L true NO965593L (en) 1997-02-26

Family

ID=6521865

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965593A NO965593L (en) 1994-06-30 1996-12-27 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria

Country Status (9)

Country Link
EP (1) EP0804211A1 (en)
JP (1) JP3031718B2 (en)
AU (1) AU2888495A (en)
CA (1) CA2194138A1 (en)
CZ (1) CZ285731B6 (en)
DE (1) DE4422859C2 (en)
NO (1) NO965593L (en)
PL (1) PL317892A1 (en)
WO (1) WO1996000579A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013485A (en) * 1996-05-07 2000-01-11 Thymopharma, Ag Low-molecular weight active ingredient extract from yeasts and method for producing it
AU726734B2 (en) * 1996-11-13 2000-11-16 Centenary Institute Of Cancer Medicine & Cell Biology Mycobacterium cell wall compositions
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
US20030108527A1 (en) * 1999-12-28 2003-06-12 Tsukasa Seya Maturation-promoting agent for immature dendrtic cells
DE19963840A1 (en) * 1999-12-30 2001-09-13 Erika Von Mutius Composition for the prevention and treatment of allergic diseases
WO2002066055A1 (en) 2001-02-20 2002-08-29 Maruho Co., Ltd. NOVEL MEDICINAL USE OF α ANTIGEN OR α ANTIGEN GENE
WO2002101026A2 (en) 2001-06-11 2002-12-19 Applied Nanosystems B.V. Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms
BR0303387A (en) * 2002-03-13 2004-07-20 Rajiv Indravadan Modi Method for the treatment of asthma, mycobacterium w, e, Process for the manufacture of a pharmaceutical composition usable for the treatment of asthma
DE502004008649D1 (en) * 2004-09-18 2009-01-22 Protectimmun Gmbh Barn dust extract for protection against allergies
EP1964570B1 (en) 2007-03-02 2012-11-21 Protectimmun GmbH Pharmaceutical compound to protect against allergies and inflammatory illnesses
DE202007003266U1 (en) 2007-03-02 2008-07-17 Bufe, Albrecht, Prof. Dr. Med. Pharmaceutical composition for protection against allergies and inflammatory diseases
EP2346512A1 (en) 2008-08-16 2011-07-27 Protectimmun GmbH Composition for prevention and treatment of allergic and/or inflammatory diseases
SG189365A1 (en) * 2010-10-13 2013-05-31 Bioniche Urology Ip Inc Compositions de membranes cellulaires et d'acide ribonucléique bactériens, et leurs procédés de fabrication et d'utilisation
EP3893896A1 (en) * 2018-12-14 2021-10-20 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Barn dust extract for the prevention and treatment of diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
JPS54140710A (en) * 1978-03-10 1979-11-01 Mitsui Toatsu Chem Inc Anti-tumor substance and its preparation
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof

Also Published As

Publication number Publication date
WO1996000579A1 (en) 1996-01-11
DE4422859C2 (en) 2000-10-05
JPH09507857A (en) 1997-08-12
DE4422859A1 (en) 1996-01-11
NO965593D0 (en) 1996-12-27
JP3031718B2 (en) 2000-04-10
EP0804211A1 (en) 1997-11-05
AU2888495A (en) 1996-01-25
PL317892A1 (en) 1997-04-28
CZ285731B6 (en) 1999-10-13
CZ375396A3 (en) 1997-06-11
CA2194138A1 (en) 1996-01-11

Similar Documents

Publication Publication Date Title
NO965593L (en) Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria
ES2167550T3 (en) STRUCTURAL HARMING SYSTEMS.
TR199701544T1 (en) New dolastatin derivatives, their preparation and use.
ES2008871B3 (en) SOLENOID VALVE.
NO20013982L (en) Substituted 1-Oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical preparations to reduce inflammatory cycotin levels
NO960183L (en) Device for adjusting an office chair or the like.
DE69204429D1 (en) Lighting device, especially for rooms without natural light.
NO931301L (en) HOLE ELECTRODE FOR AN ELECTROCHEMICAL CELL PROVIDED IN AT LEAST ONE INPUT AND GAS OUTPUT AND ELECTROCHEMICAL CELL CONTAINING SUCH AN ELECTRODE
ES283335U (en) Expansion valve.
NO923956L (en) DEVICE FOR A PIPE PIPE
ATE148270T1 (en) STRUCTURE FOR A DIELECTRIC RESONATOR
ATE215598T1 (en) MONOCLONAL ANTIBODIES THAT RECOGNIZE FLK-2 RECEPTORS AND ISOLATION OF PRIMITIVE HEMATOPOIETIC STEM CELL POPULATIONS
DK152890D0 (en) METHOD OF DETERMINING THE TYPE AND SERIOUS OF PARODONTAL DISEASES
IT1260355B (en) PERFECT MAGAZINE FOR PORTABLE FIREARMS
SE9702336D0 (en) Diaphragm-controlled valve
FR2359629A1 (en) IMPROVEMENT IN ISOTOPIC ENRICHMENT FACILITIES BY SELECTIVE GAS DIFFUSION EQUIPPED WITH MOTORCOMPRESSORS
IT225539Y1 (en) EXTENSION SYSTEM FOR TABLES
JPS6472654A (en) Inspecting device for calling condition
JPS5712176A (en) Flush valve
DK164373C (en) GAS REDUCTION VALVE WITH VIP MEMBRANE
ATE29288T1 (en) OIL BURNER PUMP.
Changdu et al. The Basic Characteristics of Plant Communities, Flora and Their Distribution in the Sandy District of Grubantungut
JPS5728998A (en) Slide sealing device
Christianson Sigmund, Paul E., ed.," Nicholas of Cusa: The Catholic Concordance"(Book Review)
Thompson Beyond the fringe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application